Showing results (1-10 of 492) with videos related to
Sort By:
Pageof 50
Journal of Hepatology|September 20, 2016
Second generation direct-acting antivirals - Do we expect major improvements?Jordan J Feld, Graham R FosterSeminars in Liver Disease|May 1, 2014
Interferon-free strategies with a nucleoside/nucleotide analogueJordan J FeldAntiviral Research|February 20, 2014
The beginning of the end: what is the future of interferon therapy for chronic hepatitis C?Jordan J FeldDigestive Diseases (Basel, Switzerland)|May 4, 2017
Hepatitis B Reactivation: The Controversies ContinueJordan J FeldBest Practice & Research. Clinical Gastroenterology|December 4, 2012
Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infectionJordan J FeldThe Journal of Infectious Diseases|October 13, 2023
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?Jordan J FeldCurrent Drug Targets|August 26, 2015
Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress ContinuesJordan J FeldNature Reviews. Gastroenterology & Hepatology|May 6, 2016
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insightsMatthias Götte, Jordan J FeldCurrent Opinion in Rheumatology|May 21, 2014
Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agentsJoshua Juan, Jordan J FeldGastroenterology|October 28, 2018
What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?George N Ioannou, Jordan J FeldPageof 50